Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deals Of The Week: AstraZeneca/Vanderbilt, Medicago, OcellO/Merus

Jan 21 2013

• By Stacy Lawrence and Paul Bonanos

Related Content

AstraZeneca Teams With Vanderbilt In Neuroscience Pact

Jan 15 2013

AstraZeneca’s Executive Shakeup Includes Global Strategist To Be Named Later

Jan 16 2013

AstraZeneca’s Ardea Acquisition: A Rich Deal Spurred By Phase III Gout Candidate

Apr 23 2012

Astra Wins MedImmune Auction; $15.6 Billion Price Tag Raises Eyebrows

Apr 30 2007

AstraZeneca, BMY To Target Disease Management And Primary Care Synergies With Amylin Acquisition

Jul 03 2012

Related Companies

AstraZeneca PLC

Sanofi

MedImmune LLC

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Ardea Biosciences, Inc.

Vanderbilt University

Vanderbilt University

US Department of Health and Human Services

Johnson & Johnson

Johnson & Johnson

University of Pennsylvania

Medicago Inc.

Mitsubishi Tanabe Pharma Corporation

Merus N.V.

Novartis AG

Leiden University

Additional Topics

Deals BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window